Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Capmatinib Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chugai obtains Japanese approval for FoundationOne Liquid CDx Genomic Profile
    Chugai obtains Japanese approval for FoundationOne Liquid CDx Genomic Profile

    27 May 2023

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=159395&sid=2

    PHARMABIZ
    27 May 2023
    Share Share
    Novartis announces MET inhibitor Tabrecta™ approved in Japan METex14
    Novartis announces MET inhibitor Tabrecta™ approved in Japan METex14

    29 Jun 2020

    // PRESS RELEASE

    https://www.novartis.com/news/media-releases/novartis-announces-met-inhibitor-tabrecta-approved-japan-advanced-non-small-cell-lung-cancer-metex14

    PRESS RELEASE
    29 Jun 2020
    Share Share
    Chugai gets Japanese approval for expanded use of FoundationOne CDx Genomic
    Chugai gets Japanese approval for expanded use of FoundationOne CDx Genomic

    29 May 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=126470&sid=2

    PHARMABIZ
    29 May 2020
    Share Share
    Novartis leans into digital for mid-pandemic lung cancer launch
    Novartis leans into digital for mid-pandemic lung cancer launch

    11 May 2020

    // Carly Helfand FIERCEPHARMA

    https://www.fiercepharma.com/marketing/novartis-leans-into-digital-for-mid-pandemic-lung-cancer-launch

    Carly Helfand FIERCEPHARMA
    11 May 2020
    Share Share
    FDA okays Tabrecta, adds indication for Farxiga
    FDA okays Tabrecta, adds indication for Farxiga

    09 May 2020

    // Renee Matthews RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/5/notable-approvals-fda-approves-tabrecta-adds-indic

    Renee Matthews RAPS
    09 May 2020
    Share Share
    FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14
    FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14

    08 May 2020

    // PHARMAFILE

    http://www.pharmafile.com/news/548156/fda-approval-tabrecta-metastatic-non-small-cell-lung-cancer-metex14

    PHARMAFILE
    08 May 2020
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.